BridgeBio Pharma, Inc. (BBIO)
67.74
+0.19
(+0.28%)
USD |
NASDAQ |
Oct 21, 16:00
67.76
+0.02
(+0.03%)
After-Hours: 20:00
BridgeBio Pharma Net Income (Annual) : -732.94M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -732.94M |
| December 31, 2024 | -543.35M |
| December 31, 2023 | -653.25M |
| December 31, 2022 | -484.65M |
| December 31, 2021 | -586.45M |
| Date | Value |
|---|---|
| December 31, 2020 | -505.49M |
| December 31, 2019 | -288.58M |
| December 31, 2018 | -169.45M |
| December 31, 2017 | -43.83M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Alnylam Pharmaceuticals, Inc. | 313.75M |
| Pfizer Inc. | 7.787B |
| Ionis Pharmaceuticals, Inc. | -381.39M |
| Vertex Pharmaceuticals, Inc. | 3.953B |
| ACADIA Pharmaceuticals, Inc. | 391.00M |